Magnetic Device for Isolation of Cells and Biomolecules in a Microfluidic Environment
The present invention features a new and useful magnetic device and methods of its use for isolation, enrichment, and purification of cells, proteins, DNA, and other molecules. In general the device includes magnetic regions or obstacles to which magnetic particles can bind. The chemical groups, i.e., capture moieties, on the surface of the magnetic particles may then be used to bind particles, e.g., cells, or molecules of interest from complex samples, and the bound species may then be selectively released for downstream collection or further analysis.
1 .- 54 . (canceled)
55 . The method of enriching, from a maternal blood sample, fetal cells that can be attracted by a magnetic field, wherein said maternal blood sample comprises said fetal blood cells and cells of a second, different type, said method comprising
a) introducing said blood sample into a first microfluidic channel,
b) either:
(i) applying a magnetic field to said maternal blood sample to attract said fetal cells to yield a first enriched sample that is enriched in said fetal cells or
(ii) subjecting a biological sample to a size-based separation, in which said fetal cells are separated from cells of said second type by passage through a two dimensional array of obsticals, to yield a first enriched sample that is enriched in said fetal cells, and
c) either:
(i) applying a magnetic field to said first enriched sample to attract said fetal cells to yield a second enriched sample that is more enriched in said fetal cells than said first enriched sample or
(ii) subjecting said first enriched sample to a size-based separation, in which said fetal cells are separated from cells of said second type by passage through a two dimensional array of obstacles, to yield a second enriched sample that is more enriched in said fetal cells than said first enriched sample,
wherein if a magnetic field is applied in step (b), size-based separation is performed in step (c), and vice versa, wherein said steps of applying of said magnetic field and carrying out size-base separation occur in one or more microfluidic channels.
56 . The method of claim 55 , wherein said fetal cells comprise fetal blood cells.
57 . The method of claim 55 , wherein said fetal cells are attracted to said magnetic field in plurality of spatially resolved regions.
58 . The method of claim 55 , wherein said magnetic field is generated by a permanent magnet.
59 . The method of claim 55 , wherein said magnetic field is generated by a non-permanent magnet.
60 . The method of claim 55 , further comprising contracting said maternal blood sample or first enriched sample with a diluent prior to, during, or after said introducing.
61 . The method of claim 60 wherein said diluent comprises a reagent capable of chemically modifying said fetal cells.
62 . The method of claim 60 , wherein said diluent comprises a reagent capable of eliciting a cellular response in said fetal cells.
63 . The method of claim 55 , wherein said fetal cells are attracted to said magnetic field based on a molecular paramagnetic entity.
64 . The method of claim 55 , wherein said molecular paramagnetic entity is an iron-containing protein.
65 . The method of claim 55 , wherein said magnetic filed is non-uniform.
66 . The method of claim 55 , wherein at least 60% of fetal cells are retained in said second enriched sample.
67 . The method of claim 55 , wherein at least 70% of fetal cells of said second type are not retained in said second enriched sample.
68 . The method of claim 55 , wherein said cells of said second type are not attracted to a magnetic filed.
69 . The method of claim 55 , wherein said fetal cells comprise a CD71 receptor.
70 . The method of claim 55 , wherein step (b) comprises size-based separation and step (c) comprises applying said magnetic filed.
71 . The method of claim 70 , further comprising contacting said maternal blood or first enriched sample with a diluent prior to, during, or after said introducing.
72 . The method of claim 71 , wherein said diluent comprises a reagent capable of chemically modifying said fetal cells.
73 . The method of claim 71 , wherein said diluent comprises a reagent capable of eliciting a cellular response in said fetal cells.
74 . The method of claim 70 , wherein said fetal cells comprise fetal blood cells.
75 . The method of claim 63 , wherein said molecular paramagnetic entity is not an antibody.